Skip to main content
Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
4.320
-0.230 (-5.05%)
Nov 20, 2024, 4:00 PM EST - Market closed

Champions Oncology Revenue

Champions Oncology had revenue of $14.06M in the quarter ending July 31, 2024, with 11.94% growth. This brings the company's revenue in the last twelve months to $51.66M, down -1.96% year-over-year. In the fiscal year ending April 30, 2024, Champions Oncology had annual revenue of $50.16M, down -6.90%.

Revenue (ttm)
$51.66M
Revenue Growth
-1.96%
P/S Ratio
1.13
Revenue / Employee
$245,976
Employees
210
Market Cap
58.73M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 202450.16M-3.72M-6.90%
Apr 30, 202353.87M4.76M9.69%
Apr 30, 202249.11M8.07M19.66%
Apr 30, 202141.04M8.92M27.76%
Apr 30, 202032.12M5.06M18.68%
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro
Apr 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Agenus 160.43M
Xtant Medical Holdings 113.86M
Spero Therapeutics 106.46M
Celularity 42.69M
electroCore 23.33M
Hyperfine 13.26M
VolitionRx 1.29M
Entera Bio 99.00K
Revenue Rankings

CSBR News

More News